Phase II Trial of Bevacizumab in the Treatment of Persistent or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Global cancer statistics

2011 • 55,498 citations

Global Cancer Statistics, 2002

2005 • 17,966 citations

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

2000 • 15,583 citations

THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL

1934 • 4,169 citations

Modelling Survival Data in Medical Research

1994 • 1,036 citations

Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study

2005 • 528 citations

Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies

2006 • 498 citations

Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. A statement for health professionals from a special writing group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association.

1994 • 310 citations

Multimodality Therapy for Locally Advanced Cervical Carcinoma: State of the Art and Future Directions

2007 • 250 citations

Paclitaxel and Cisplatin as First-Line Therapy in Recurrent or Advanced Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

1999 • 208 citations

Quality of Life Outcomes From a Randomized Phase III Trial of Cisplatin With or Without Topotecan in Advanced Carcinoma of the Cervix: A Gynecologic Oncology Group Study

2005 • 131 citations

Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy

2003 • 127 citations

Topotecan in Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology Group

2000 • 122 citations

Optimal flexible designs in phase II clinical trials

1998 • 120 citations

Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma?

2007 • 96 citations

Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study

2008 • 93 citations

Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer

2005 • 88 citations

Evaluation of Gemcitabine in Patients with Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology Group

2000 • 83 citations

Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets

2005 • 60 citations

Prolonged Oral Etoposide in Recurrent or Advanced Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

1998 • 41 citations

A Phase II Trial of Isotretinoin and Alpha Interferon in Patients With Recurrent Squamous Cell Carcinoma of the Cervix

1998 • 20 citations

Cisplatin and Pentoxifylline in Advanced or Recurrent Squamous Cell Carcinoma of the Cervix: A Phase II Trial of the Gynecologic Oncology Group

2000 • 19 citations

Phase II Evaluation of Altretamine for Advanced or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

1996 • 16 citations

Invasive Cervical Cancer

2007 • 12 citations

Factors predictive of response to cisplatin-based chemotherapy in stage IVB persistent or recurrent cervical carcinoma: A multivariate analysis of three Gynecologic Oncology Group trials

2007 • 4 citations